CAMBRIDGE, Mass.--(BUSINESS WIRE)--Millennium: The Takeda Oncology Company today announced that data on two investigational compounds in the Company’s expanded oncology pipeline, MLN9708 and TAK-701, will be presented at the 100th American Association for Cancer Research (AACR) Annual Meeting to be held April 18 – 22, 2009 in Denver, CO.
